Literature DB >> 3484965

Transitory hypomegakaryocytic thrombocytopenia: aetiological association with ethanol abuse and implications regarding regulation of human megakaryocytopoiesis.

A M Gewirtz, R Hoffman.   

Abstract

We studied a patient with a long history of ethanol abuse who presented to the hospital with profound weakness, anaemia and thrombocytopenia. Evaluation of these problems revealed the patient's bone marrow to be hypercellular but severely iron depleted and almost totally devoid of morphologically recognizable megakaryocytes. However, we were able to detect the presence of non-morphologically recognizable, immature megakaryocytes in the same sample using an immunochemical detection technique. This circumstance allowed us to study the relative importance of both megakaryocyte maturation and peripheral blood platelet count on the production of megakaryocyte colony stimulating activity (Meg-CSA), a putative regulator of the megakaryocyte colony forming unit (CFU-M). The results of our investigations disclosed a rapid decline in serum Meg-CSA levels which preceded recovery of the platelet count and appeared to coincide with the maturation of megakaryocytes into the morphologically recognizable pool. The effect of ETOH on the patient's CFU-M cloning efficiency was also studied. ETOH in amounts up to 454 mg/dl did not inhibit cloning of the patient's peripheral blood CFU-M in plasma clot cultures. Our results suggest that regulation of Meg-CSA production is a complex function which appears to be dependent on a number of factors including the level of megakaryocyte maturation in the marrow. We also speculate that ethanol associated thrombocytopenia may occasionally be brought about by a disruption in the process of megakaryocyte maturation at the level of a progenitor more mature than the CFU-M.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484965     DOI: 10.1111/j.1365-2141.1986.tb02937.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Acquired amegakaryocytic thrombocytopenic purpura induced by percutaneous ethanol injection during treatment of hepatocellular carcinoma: A case report.

Authors:  Ding-Lun Ai; Bo-Tao Li; Xiao-Ming Peng; Lin-Zhi Zhang; Jing-Yan Wang; Yun Zhao; Bin Yang; Qiang Yu; Chun-Zi Liu; Ning Yang; Hua-Ming Wang; Lin Zhou
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

2.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

Authors:  A M Gewirtz; B Calabretta; B Rucinski; S Niewiarowski; W Y Xu
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

4.  Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura.

Authors:  E Mulroy; S Gleeson; S Chiruka
Journal:  Case Rep Hematol       Date:  2015-04-05

5.  Platelet IgG antibodies are significantly increased in chronic liver disease.

Authors:  Dimitrios Christodoulou; Konstantinos Katsanos; Eleftheria Zervou; Vasileios Theopistos; Athanasios Papathanasopoulos; Leonidas Christou; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.